Skip to content
  • Sunday, 26 July 2026
  • 2:53 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Chinese Firms Landed 6 of 26 Major Pharma Deals in 16 Months, Worth $53 Billion
Laboratory Automation & Robotics

Chinese Firms Landed 6 of 26 Major Pharma Deals in 16 Months, Worth $53 Billion

Lana Keisha Apr 28, 2026 0

Over the past 16 months, Chinese-domiciled biopharmaceutical companies have emerged as formidable players in the global drug development landscape, securing…

Read More
Neuroscience & Brain Research

Internalized Stress Linked to Heightened Risk of Memory Loss in Older Chinese Americans According to Rutgers Study

Rifan Muazin Apr 28, 2026 0

New research from Rutgers Health suggests that the psychological tendency to turn stress inward—a phenomenon often characterized by feelings of…

Read More
Laboratory Automation & Robotics

Chinese firms landed 6 of 26 major pharma deals in 16 months, worth $53 billion

Lana Keisha Apr 21, 2026 0

Over the past 16 months, Chinese-domiciled biotechnology companies have emerged as formidable forces in the global pharmaceutical landscape, featuring prominently…

Read More
Pharmaceutical R&D

AbbVie Secures Up to $745 Million in Pain Pipeline Deal with Chinese Biopharma Haisco

Teuku Ryan Apr 13, 2026 0

AbbVie, a global biopharmaceutical giant, has finalized a significant strategic collaboration with Haisco Pharmaceutical Group, a prominent Chinese biopharmaceutical company.…

Read More

Posts pagination

1 2
Deciphering the Inflammatory Niche: How Bone Marrow Microenvironments Drive the Progression of Pre-Leukemic States and Age-Related Blood DisordersUnlocking Evolutionary Accelerators: Flipped DNA Segments Drive Rapid Speciation in Cichlid FishNovo Nordisk’s triple agonist delivers up to 19.7% average weight loss in Phase 2 trialHKUMed Researchers Identify Piezo1 Protein as the Key Exercise Sensor in Bone Maintenance and Potential Target for Osteoporosis Treatment
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ